000			01947 a2200529 4500
005			20250516035150.0
264		0	_c20120727
008			201207s 0 0 eng d
022			_a1552-4604
024	7		_a10.1177/0091270011402826 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhu, Rui
245	0	0	_aThe pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid. _h[electronic resource]
260			_bJournal of clinical pharmacology _cApr 2012
300			_a511-9 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650	0	4	_aAdministration, Oral
650	0	4	_aAge Factors
650	0	4	_aAntitubercular Agents _xadministration & dosage
650	0	4	_aArylamine N-Acetyltransferase _xgenetics
650	0	4	_aChild, Preschool
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHIV Infections _xtransmission
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInfectious Disease Transmission, Vertical
650	0	4	_aIsoniazid _xadministration & dosage
650	0	4	_aLatent Tuberculosis _xprevention & control
650	0	4	_aMale
650	0	4	_aPharmacogenetics
650	0	4	_aPregnancy
650	0	4	_aPregnancy Complications, Infectious _xepidemiology
650	0	4	_aProspective Studies
650	0	4	_aSouth Africa
650	0	4	_aTuberculosis _xprevention & control
700	1		_aKiser, Jennifer J
700	1		_aSeifart, Heiner I
700	1		_aWerely, Cedric J
700	1		_aMitchell, Charles D
700	1		_aD'Argenio, David Z
700	1		_aFletcher, Courtney V
773	0		_tJournal of clinical pharmacology _gvol. 52 _gno. 4 _gp. 511-9
856	4	0	_uhttps://doi.org/10.1177/0091270011402826 _zAvailable from publisher's website
999			_c20821660 _d20821660